Evotec AG and Sanofi will jointly develop a beta cell replacement therapy to restore function in diabetic patients under an alliance announced Aug. 7.
The deal widens existing areas of cooperation between the German biotech and French pharma and could generate different levels of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?